Lifestance Health Group, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
LifeStance Health Group, Inc. announced significant revenue increases and improved operational metrics for the second quarter of 2026, alongside ongoing efforts to address internal control deficiencies.
NASDAQ
LifeStance Health Group, Inc. reported a return to net income in the third quarter of 2025 with a 16% revenue increase, despite ongoing material weaknesses in internal financial controls.
NASDAQ
LifeStance Health Group, Inc. reported an 11% revenue increase and significantly reduced its net loss for the second quarter and first half of 2025, driven by clinician hiring and patient visit growth.
NASDAQ
LifeStance Health Group's Q1 2025 shows revenue growth of 11% year-over-year, but material weaknesses in internal controls persist.
NASDAQ
LifeStance Health Group's Q3 2024 results show a 19% year-over-year increase in total revenue, driven by growth in patient visits and modest payor rate increases.
NASDAQ
LifeStance Health Group, a national outpatient mental health provider, announced a 20% increase in revenue for the second quarter of 2024, driven by clinician growth and patient visits, while still reporting a net loss.
NASDAQ
LifeStance Health Group's first quarter 2024 results show a 19% increase in revenue compared to the same period last year, driven by growth in clinician numbers and patient visits.